BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1770155)

  • 1. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse.
    Harvey NS; Kay R
    J Clin Psychopharmacol; 1991 Dec; 11(6):362-7. PubMed ID: 1770155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.
    Goodwin GM
    Br J Psychiatry; 1994 Feb; 164(2):149-52. PubMed ID: 8173817
    [No Abstract]   [Full Text] [Related]  

  • 3. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance with maintenance treatment in bipolar disorder.
    Keck PE; McElroy SL; Strakowski SM; Bourne ML; West SA
    Psychopharmacol Bull; 1997; 33(1):87-91. PubMed ID: 9133756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine withdrawal increases lithium blood levels.
    Mester R; Toren P; Mizrachi I; Wolmer L; Karni N; Weizman A
    Biol Psychiatry; 1995 Mar; 37(5):348-50. PubMed ID: 7748990
    [No Abstract]   [Full Text] [Related]  

  • 6. Lithium treatment present and future.
    Gomez GE
    J Psychosoc Nurs Ment Health Serv; 2001 Aug; 39(8):31-7. PubMed ID: 11503429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressed emotion, affective style, lithium compliance, and relapse in recent onset mania.
    Miklowitz DJ; Goldstein MJ; Nuechterlein KH; Snyder KS; Doane JA
    Psychopharmacol Bull; 1986; 22(3):628-32. PubMed ID: 3797569
    [No Abstract]   [Full Text] [Related]  

  • 8. Compliance with long-term lithium treatment in major affective disorders.
    Danion JM; Neunreuther C; Krieger-Finance F; Imbs JL; Singer L
    Pharmacopsychiatry; 1987 Sep; 20(5):230-1. PubMed ID: 3671494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
    Fawcett J; Kravitz HM
    J Clin Psychiatry; 1985 Feb; 46(2):58-60. PubMed ID: 3968046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium-magnesium relationship in red blood cells during lithium prophylaxis.
    Rybakowski J; Szajnerman Z
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Sep; 9(5):242-6. PubMed ID: 996088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lithium strumas and their psychiatric relevance].
    Felber W; König L
    Psychiatr Prax; 1988 Mar; 15(2):57-61. PubMed ID: 3133682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of erythrocyte glycine levels during lithium treatment of affective disorders.
    Rosenblatt S; Leighton WP; Chanley JD
    Psychiatry Res; 1982 Apr; 6(2):203-14. PubMed ID: 6953459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of lithium transport through cell membrane in bipolar affective disorder on the model of red cell].
    Rybakowski J
    Pol Tyg Lek; 1980 Jan; 35(3):103-5. PubMed ID: 7367331
    [No Abstract]   [Full Text] [Related]  

  • 15. Tryptophan depletion in recently manic patients treated with lithium.
    Cassidy F; Murry E; Carroll BJ
    Biol Psychiatry; 1998 Feb; 43(3):230-2. PubMed ID: 9494705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long term prophylaxis of affective disorders.
    Koukopoulos A; Reginaldi D; Minnai G; Serra G; Pani L; Johnson FN
    Adv Biochem Psychopharmacol; 1995; 49():127-47. PubMed ID: 7653332
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening and evaluation on predictive factors in lithium carbonate maintenance treatment of manic-depressive disorders].
    Jiang ZN
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Dec; 23(6):324-8, 383. PubMed ID: 1982995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
    Rosa AR; Marco M; Fachel JM; Kapczinski F; Stein AT; Barros HM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):217-24. PubMed ID: 16982121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of clonazepam for bipolar affective disorder.
    Sachs GS
    J Clin Psychiatry; 1990 May; 51 Suppl():31-4; discussion 50-3. PubMed ID: 1970815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence.
    Maarbjerg K; Aagaard J; Vestergaard P
    Pharmacopsychiatry; 1988 May; 21(3):121-5. PubMed ID: 3406049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.